3-chloro-N-{2,2-dichloro-1-[N'-cyano-N''-(6-fluoropyridin-3-yl)guanidino]propyl}benzamide

ID: ALA238638

PubChem CID: 10203855

Max Phase: Preclinical

Molecular Formula: C17H14Cl3FN6O

Molecular Weight: 443.70

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(Cl)(Cl)C(NC(=O)c1cccc(Cl)c1)N/C(=N/C#N)Nc1ccc(F)nc1

Standard InChI:  InChI=1S/C17H14Cl3FN6O/c1-17(19,20)15(26-14(28)10-3-2-4-11(18)7-10)27-16(24-9-22)25-12-5-6-13(21)23-8-12/h2-8,15H,1H3,(H,26,28)(H2,24,25,27)

Standard InChI Key:  PLJKBKKKCUHYBD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 29  0  0  0  0  0  0  0  0999 V2000
    6.0402  -17.5041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0391  -18.3315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7539  -18.7444    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4703  -18.3310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4675  -17.5005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7521  -17.0914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1804  -17.0853    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8964  -17.4951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6093  -17.0799    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8995  -18.3201    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1866  -18.7353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4667  -19.1417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.3253  -17.4897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0383  -17.0745    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.3284  -18.3147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3208  -19.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1534  -18.3170    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    9.5034  -18.3147    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   11.7543  -17.4843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4672  -17.0692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7574  -18.3093    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.1803  -17.4811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8928  -17.0666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8901  -16.2407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1691  -15.8311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4596  -16.2480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3243  -18.7434    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   13.1631  -15.0061    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
 13 14  1  0
  5  7  1  0
 13 15  1  0
  3  4  2  0
 15 16  1  0
  7  8  1  0
 15 17  1  0
 15 18  1  0
  8  9  1  0
 14 19  1  0
  4  5  1  0
 19 20  1  0
  8 10  2  0
 19 21  2  0
  2  3  1  0
 20 22  2  0
 10 11  1  0
 22 23  1  0
  5  6  2  0
 23 24  2  0
 11 12  3  0
 24 25  1  0
  6  1  1  0
 25 26  2  0
 26 20  1  0
  9 13  1  0
  2 27  1  0
  1  2  2  0
 25 28  1  0
M  END

Associated Targets(Human)

KCNJ11 Tclin Potassium channel, inwardly rectifying, subfamily J, member 11 (112 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 443.70Molecular Weight (Monoisotopic): 442.0279AlogP: 3.66#Rotatable Bonds: 5
Polar Surface Area: 102.20Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.14CX LogD: 4.14
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.16Np Likeness Score: -1.71

References

1. Perez-Medrano A, Brune ME, Buckner SA, Coghlan MJ, Fey TA, Gopalakrishnan M, Gregg RJ, Kort ME, Scott VE, Sullivan JP, Whiteaker KL, Carroll WA..  (2007)  Structure-activity studies of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladder.,  50  (24): [PMID:17973362] [10.1021/jm7010194]

Source